A

Albireo Pharma Inc
F:BDQM

Watchlist Manager
Albireo Pharma Inc
F:BDQM
Watchlist
Price: 41.41 EUR 0.46% Market Closed
Market Cap: 857.2m EUR

Wall Street
Price Targets

BDQM Price Targets Summary
Albireo Pharma Inc

There are no price targets for BDQM.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Albireo Pharma Inc Competitors:
Price Targets
AMGN
Amgen Inc
4% Upside
4974
Takara Bio Inc
28% Upside
GNS
Genus PLC
9% Upside
4593
Healios KK
18% Downside
6990
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
13% Downside
RXRX
Recursion Pharmaceuticals Inc
6% Upside
ANAB
AnaptysBio Inc
61% Upside
ZNTL
Zentalis Pharmaceuticals Inc
310% Upside

Revenue
Forecast

Revenue Estimate
Albireo Pharma Inc

The compound annual growth rate of Albireo Pharma Inc's revenue for the next 1 year is 36%.

N/A
Past Growth
36%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Albireo Pharma Inc

Operating Income forecast
is not available for
Albireo Pharma Inc

Net Income
Forecast

Net Income Estimate
Albireo Pharma Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BDQM's stock price target?
Not Available

BDQM doesn't have any price targets made by Wall Street professionals.

What is Albireo Pharma Inc's Revenue forecast?
Projected CAGR
36%

The compound annual growth rate of Albireo Pharma Inc's revenue for the next 1 year is 36%.

Back to Top